Draft for editorial review
A new draft post that separates trial phases into a standalone article for patients who want a quicker reference than the full clinical trials guide.
Clinical Trial Phases Explained
Draft dated 8 April 2026 by the TrialConnect team
Why phases exist
Clinical trial phases are a way of building evidence step by step. Earlier phases usually ask more basic safety and dosing questions. Later phases usually ask whether a treatment works well enough compared with existing care.
Not every study fits neatly into one phase. Some trials combine phases, and observational or device studies may use different language.
Phase 1: first questions about safety
Phase 1 trials are often the first time a treatment is tested in people, although the exact setup depends on the disease area. The main focus is safety, side effects, dose, and how the body handles the treatment.
These trials are usually small. In some areas they involve healthy volunteers; in others, such as cancer, they often involve patients with a specific diagnosis.
Phase 2: early signs of effect
Phase 2 trials usually involve more participants than Phase 1. Researchers continue to monitor safety while looking for signs that the treatment may help the condition being studied.
A Phase 2 result can be promising without being final. Researchers may still need a larger trial to understand how the treatment compares with current care.
Phase 3: comparison at larger scale
Phase 3 trials often compare a new treatment or approach with standard care, placebo, or another active option. They usually involve larger groups and more sites.
Regulators and clinical guideline groups often rely heavily on Phase 3 evidence when deciding whether a treatment should become widely available.
Phase 4: learning after approval
Phase 4 studies happen after a treatment is already approved or in routine use. They can track longer-term safety, real-world outcomes, or how a treatment works in broader groups of patients.
These studies can still be important. Some side effects or usage patterns only become clear when more people have used a treatment over time.
What to ask about any phase
- What is the main question this trial is trying to answer?
- How much is already known about this treatment?
- What are the expected visits, tests, and follow-up?
- What are the alternatives if I do not join?
Suggested next step
When viewing a trial, look for the phase and read it alongside the purpose, treatment, and eligibility criteria.
Search trials